Latest Breaking News On - Jeffrey ecsedy - Page 1 : comparemela.com

Ikena Oncology Inc (IKNA) Presents New Preclinical Data

Ikena Oncology Inc (IKNA) Presents New Preclinical Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaMihir rajurkarJeffrey ecsedyLuke shiplolifesci communicationsBristol myers squibbIkena oncology incWall streetMolecular targetsCancer therapeuticsAdaptive responseIkena senior scientistChief development officerEpithelioid hemangioendotheliomaIkena oncologyikena oncologyBristol myersLooking statementsthis

Ikena Oncology Presents Preclinical Data at the 34th EORTC-NCI-AACR Symposium on Novel TEAD Inhibitor, IK-930, Combating Therapeutic Resistance

Ikena Oncology Presents Preclinical Data at the 34th EORTC-NCI-AACR Symposium on Novel TEAD Inhibitor, IK-930, Combating Therapeutic Resistance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesComunidad autonoma de catalunaMihir rajurkarJeffrey ecsedyLuke shiplolifesci communicationsBristol myers squibbIkena oncology incMolecular targetsCancer therapeuticsAdaptive responseIkena senior scientistChief development officerEpithelioid hemangioendotheliomaIkena oncologyikena oncologyBristol myersLooking statementsthis

Ikena Oncology, Vall d Hebron Institute Partner on Biomarker Research

The research on resistance mechanisms and drug combinations could aid the development of Ikena's drugs targeting the Hippo and RAS pathways.

United statesIsrael generalComunidad autonoma de catalunaMerck keytrudaBristol myers squibb opdivoJeffrey ecsedyJosep taberneroHebron institute of oncologyIkena oncologyHebron instituteBristol myers squibb

BioSpace Movers & Shakers, Dec 10

As the year comes to an end, biopharma and life sciences companies are strengthening their leadership teams and boards with the latest round of Movers & Shakers.

North carolinaUnited statesUnited kingdomNordrhein westfalenCity ofSan franciscoZach collinsLee giguereCassidy blundellJeffrey ecsedyBill quirkBecky lillieSteve malaskaMichelle zhangMegan sniecinskiSaraswathy nochur

Chutes & Ladders—Former FDA leader Hahn lands at cancer blood test maker Harbinger Health

Former FDA head Stephen Hahn is adding a new title to his role at Flagship Pioneering: CEO of the incubator's blood cancer test startup Harbinger Health. Takeda's oncology leader Rachael Brake heads to Corbus as chief scientific officer charged with redefining scope of early-stage pipeline. Goldfinch Bio snags 13-year Ardelyx vet as CSO.

Irit rappleyLee giguereBecky lillieJames engelhartDeclan dooganSteve malaskaMatthew butenMichelle zhangMatthew truppoMichael holmesJames mutambaEhud gelblumTheravance biopharmaStephen hahnChua zhengVanessa broadhurst